Browse > Article
http://dx.doi.org/10.4014/kjmb.1210.10008

Multiplex Reverse Transcription-PCR for Simultaneous Detection of Reovirus, Bovine Viral Diarrhea Virus, and Bovine Parainfluenza Virus during the Manufacture of Cell Culture-derived Biopharmaceuticals  

Oh, Seon Hwan (Department of Biological Sciences and Biotechnology, and Center for Biopharmaceuticals Safety Validation, Hannam University)
Bae, Jung Eun (Department of Biological Sciences and Biotechnology, and Center for Biopharmaceuticals Safety Validation, Hannam University)
Kim, In Seop (Department of Biological Sciences and Biotechnology, and Center for Biopharmaceuticals Safety Validation, Hannam University)
Publication Information
Microbiology and Biotechnology Letters / v.40, no.4, 2012 , pp. 339-347 More about this Journal
Abstract
Viral safety is an important prerequisite for clinical preparations of mammalian cell culture-derived biopharmaceuticals, because numerous adventitious viruses have been contaminated during the manufacturing process. In particular, Chinese hamster ovary (CHO) cells are highly susceptible to several RNA viruses including reovirus (Reo), bovine viral diarrhea virus (BVDV), and bovine parainfluenza virus (BPIV) and there have been reports of such viral contaminations. Therefore, viral detection during the CHO cell process is necessary to ensure the safety of biopharmaceuticals against viruses. In this study, a multiplex reverse transcription (RT)-PCR assay was developed and subsequently evaluated for its effectiveness as a means to simultaneously detect Reo, BVDV, and BPIV during the manufacture of cell culture-derived biopharmaceuticals. Specific primers for Reo, BVDV, and BPIV were selected, and a multiplex RT-PCR was optimized. The sensitivity of the assay for simultaneous amplification of all viral target RNAs was $7.76{\times}10^2\;TCID_{50}/ml$ for Reo, $7.44{\times}10^1\;TCID_{50}/ml$ for BVDV, and $6.75{\times}10^1\;TCID_{50}/ml$ for BPIV. The multiplex RT-PCR was proven to be very specific to Reo, BVDV, and BPIV and was subsequently applied to the validation of CHO cells artificially infected with each virus. It could detect each viral RNA from CHO cells as well as culture supernatants. Therefore, it was concluded that the multiplex RT-PCR assay can be applied to detection of the adventitious viruses during the manufacture of cell culture-derived biopharmaceuticals.
Keywords
Multiplex RT-PCR; CHO cell; reovirus; bovine viral diarrhea virus; bovine parainfluenza virus;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Adamson, S. R. 1998. Experiences of virus, retrovirus, and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Dev. Biol. Stand. 93: 89-96.
2 Bae, J. E. and I. S. Kim. 2010. Multiplex PCR for rapid detection of minute virus of mice, bovine parvovirus, and bovine herpesvirus during the manufacture of cell culturederived biopharmaceuticals. Biotechnol. Bioprocess Eng. 15: 1031-1037.   DOI
3 Butler, M. 2005. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl. Microbiol. Biotechnol. 68: 283-291.   DOI   ScienceOn
4 Caterina, K. M., S. Frasca Jr, T. Grirshick, and M. I. Khan. 2004. Development of a multiplex PCR for detection of avian adenovirus, avian reovirus, infectious bursal diseasevirus, and chicken anemia virus. Mol. Cell. Probes 18: 293-298   DOI   ScienceOn
5 Collins P. L., R. M. Chanock, and K. McIntosh. 1996. Parainfluenza Viruses, pp. 1205-1243. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, S. E. Straus (ed..), Fields Virology, 3rd ed. Vol. 1, Lippincott-Raven Publishers, Philadelphia.
6 Collins, M. J. Jr and J. C. Parker. 1972. Murine virus contaminants of leukemia viruses and transplantable tumors. J. Natl. Cancer Inst. 49: 1139-1143.
7 Nicklas, W., V. Kraft, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296-300.
8 Robertson, J. S. 1996. Strategy for adventitious agent assays. Biologicals 88: 37-40.
9 Wit, C., C. Fautz, and Y. Xu. 2000. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture. Biologicals 28: 137-148.   DOI   ScienceOn
10 World Health Organization. 1998. WHO requirements for the use of animal cells as in vitro substrates for the production of biological. Dev. Bio. Stand. 93: 141-171.
11 Zhan, D., M. R. Roy, C. Calera, J. Cardenas, J. C. Vennari, J. W. Chen, and S. Liu. 2002. Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of mammalian cell substrate derived biotherapeutics. Biologicals 30: 259-270.   DOI   ScienceOn
12 Garnick, R. L. 1998. Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 93: 21-29.
13 Committee for Proprietary Medicinal Products (CPMP), The European Agency for the Evaluation of Medicinal Products: Human Medicines Evaluation Unit. 1996. Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses (CPMP/BWP/268/95).
14 Eloit, M. 1999. Risks of virus transmission associated with animal sera or substitutes and methods of control. Dev. Biol. Stand. 99: 9-16.
15 Garnick, R. L. 1996. Experience with viral contamination in cell culture. Dev. Biol. Stand. 88: 49-56.
16 Heinz, F., M. Collett, R. Purrchell, E. Gould, C. Howard, M. Houghton, R. Moorman, C. Rice, and H.-J. Theil. 2000. Family Flaviviridae, pp. 859-857. In M. H. V.van Regnmortel, C. M. Fanqute, D. H. L. Bishop, E. V. Carstens, M. K. Estes, S. M. Lemon, J. Manilott, M. A. Mayo, D. J. McGeoch, C. R. Pringle, R. B. Wickner (ed.), Virus Taxonomy, Proceedings of the Seventh Report of International Committee on Taxonomy of Viruses, Academic Press, San Diego.
17 Immelmann, A., O. Stamm, and K. Tarrach. 2005. Validation and quality procedures for virus and prion removal in biopharmaceuticals. BioProcess Int. 3: 38-44.
18 International Conference on Harmonisation. 1998. Q5A Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. Fedral Register. 63: 51074-51084.
19 Jacoby, R. O. and J. R. Lindsey. 1998. Risks of infection among laboratory rats and mice at major biomedical research institutions. ILAR J. 39: 266-271.   DOI   ScienceOn
20 Kärber, J. 1931. Beitrag zur kollectiven Behandlung pharmakologische Reihenversuche. Arch. Exp. Path. Pharmak. 162: 480-483.   DOI
21 Minor, P. D. 1996. Mammalian cells and their contaminants. Dev. Biol. Stand. 88: 25-29.
22 Kniazeff, A. J. 1973. Endogenous virus contaminants in fetal bovine serum and their role in tissue culture contamination. pp. 233-242. In: J. Fogh (ed..), Contamination in Tissue Culture, Academic Press, New York.
23 Kou, X., Q. Wu, D. Wang, and J. Zhang. 2008. Simultaneous detection of norovirus and rotavirus in oyster by multiplex RT-PCR. Food Control. 19: 722-726.   DOI   ScienceOn
24 Merten, O.-W. 2002. Virus contaminations of cell cultures - A biotechnological view. Cytotechnology 39: 91-116.   DOI   ScienceOn
25 Nibert, M. L. and L. A. Schiff. 2001. Reoviruses and their replication, pp. 1679-1728. In B. N. Fields, D. M Knipe, and P. M. Howley (ed.), Fields Virology, Lippincott-Raven Publisher, Philadelphia.